- Home
- PGEN vs VCV Comparison
PGEN vs VCV Comparison
Compare PGEN & VCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- VCV
- Stock Information
- Founded
- PGEN 1998
- VCV 1993
- Country
- PGEN United States
- VCV United States
- Employees
- PGEN N/A
- VCV N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- VCV Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- VCV Finance
- Exchange
- PGEN Nasdaq
- VCV Nasdaq
- Market Cap
- PGEN 448.7M
- VCV 491.4M
- IPO Year
- PGEN N/A
- VCV N/A
- Fundamental
- Price
- PGEN $1.67
- VCV $10.22
- Analyst Decision
- PGEN Strong Buy
- VCV
- Analyst Count
- PGEN 3
- VCV 0
- Target Price
- PGEN $6.00
- VCV N/A
- AVG Volume (30 Days)
- PGEN 3.0M
- VCV 107.9K
- Earning Date
- PGEN 08-13-2025
- VCV 01-01-0001
- Dividend Yield
- PGEN N/A
- VCV 4.09%
- EPS Growth
- PGEN N/A
- VCV N/A
- EPS
- PGEN N/A
- VCV 0.13
- Revenue
- PGEN $4,201,000.00
- VCV N/A
- Revenue This Year
- PGEN $256.94
- VCV N/A
- Revenue Next Year
- PGEN $759.81
- VCV N/A
- P/E Ratio
- PGEN N/A
- VCV $75.82
- Revenue Growth
- PGEN N/A
- VCV N/A
- 52 Week Low
- PGEN $0.65
- VCV $8.05
- 52 Week High
- PGEN $2.17
- VCV $10.40
- Technical
- Relative Strength Index (RSI)
- PGEN 51.21
- VCV 50.64
- Support Level
- PGEN $1.54
- VCV $9.96
- Resistance Level
- PGEN $1.85
- VCV $10.08
- Average True Range (ATR)
- PGEN 0.14
- VCV 0.14
- MACD
- PGEN -0.02
- VCV -0.01
- Stochastic Oscillator
- PGEN 40.00
- VCV 32.50
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.